The U.S. Centers for Medicare & Medicaid Services will publish the first 10 Medicare Part D drugs selected for the new Medicare Drug Price Negotiation Program by Sept. 1, CMS announced yesterday.
The negotiated maximum fair prices for these drugs
…
Category: Federal
A federal district judge in Washington, D.C., this morning ruled that Medicare Part B underpayments to hospitals for 340B drugs from 2018 to 2022 were unlawful. But in a disappointment for the hospital groups that sued, the judge declined to
…
A federal district court in South Carolina ordered 340B Report late yesterday to destroy and not release information from more than 9,000 pages of documents that the federal government filed in a public database Thursday in a community health center’s
…
The members, GOP chairs, and top-ranking Democrats of U.S. House committees for the 118th Congress still had not been formally announced this morning, three days after Republicans chose Rep. Kevin McCarthy (R-Calif.) to be House speaker.
It took four days
…
Federal Medicare officials plan to issue a proposed rule in April regarding “potential remedies” for illegal Part B drug payment cuts for 340B hospitals from 2018 through late September 2022.
The Centers for Medicare & Medicaid Services revealed April as
…
Brand drug manufacturers have asked a federal appeals court to overturn a judge’s ruling last month that Arkansas’s novel 340B anti-discrimination law is not preempted by the 340B statute nor by the U.S. Food and Drug Administration’s Risk Evaluation and
…
Swiss eye care drug manufacturer Alcon is providing refunds for charges above 340B ceiling prices on 22 NDCs for varying sales periods from Q3 2019 through Q3 2022.
The U.S. Health Resources and Services Administration posted Alcon’s public notice about
…
The U.S. House was frozen stuck this morning after the new Republican majority splintered yesterday, the first day of the 118th Congress, over who should be the next House speaker.
Representatives cannot be sworn in and the House cannot begin
…